Hemochromatosis gene status as a risk factor for Barrett's esophagus

Digestive Diseases and Sciences

Volumn 53, Issue 12, 2008, Pages 3095-3102

  Corley, Douglas A ^a,b   Kubo, Ai ^a,c   Levin, T R ^a   Block, Gladys ^d   Habel, Laurel ^a   Rumore, Gregory J ^e   Quesenberry, Charles ^a   Buffler, Patricia ^d  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Hemochromatosis; Iron

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGEAL REFLUX; GENE MUTATION; GENETIC RISK; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRON BLOOD LEVEL; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; POPULATION DYNAMICS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 55949132312     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0287-x     Document Type: Article

References (49)

1. H Pohl HG Welch 2005 The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 142 146
2. X Chen CS Yang 2001 Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention Carcinogenesis 22 1119 1129 10.1093/carcin/22.8.1119
3. X Chen YW Ding G Yang F Bondoc MJ Lee CS Yang 2000 Oxidative damage in an esophageal adenocarcinoma model with rats Carcinogenesis 21 257 263 10.1093/carcin/21.2.257
4. X Chen G Yang WY Ding F Bondoc SK Curtis CS Yang 1999 An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload Carcinogenesis 20 1801 1808 10.1093/carcin/20.9.1801
5. D Geier B Hebert A Potti 2002 Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis Anticancer Res 22 3797 3799
6. M Elmberg R Hultcrantz A Ekbom L Brandt S Olsson R Olsson S Lindgren L Lööf P Stål S Wallerstedt S Almer H Sandberg-Gertzén J Askling 2003 Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives Gastroenterology 125 1733 1741 10.1053/j.gastro. 2003.09.035
7. DR Petersen 2005 Alcohol, iron-associated oxidative stress, and cancer Alcohol 35 243 249 10.1016/j.alcohol.2005.03.013
8. RG Stevens RP Beasley BS Blumberg 1986 Iron-binding proteins and risk of cancer in Taiwan J Natl Cancer Inst 76 605 610
9. AW Hsing JK McLaughlin JH Olsen L Mellemkjar S Wacholder JF Fraumeni Jr 1995 Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark Int J Cancer 60 160 162
10. AL Fracanzani D Conte M Fraquelli E Taioli M Mattioli A Losco S Fargion 2001 Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease Hepatology 33 647 651 10.1053/jhep.2001.22506
11. A Walsh JL Dixon GA Ramm DG Hewett DJ Lincoln GJ Anderson VN Subramaniam J Dodemaide JA Cavanaugh ML Bassett LW Powell 2006 The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis Clin Gastroenterol Hepatol 4 1403 1410 10.1016/j.cgh.2006.07.009
12. CA McCune D Ravine K Carter HA Jackson D Hutton J Hedderich M Krawczak M Worwood 2006 Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients Gut 55 554 562 10.1136/gut.2005.070342
13. A Lazarescu BM Snively PC Adams 2005 Phenotype variation in C282Y homozygotes for the hemochromatosis gene Clin Gastroenterol Hepatol 3 1043 1046 10.1016/S1542-3565(05)00413-1
14. JC Barton RT Acton FW Dawkins PC Adams L Lovato C Leiendecker-Foster CE McLaren DM Reboussin MR Speechley VR Gordeuk GD McLaren P Sholinsky EL Harris 2005 Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study Genet Test 9 231 241 10.1089/gte.2005.9.231
15. E Beutler V Felitti T Gelbart N Ho 2000 The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic Ann Intern Med 133 329 337
16. P Sharma K McQuaid J Dent MB Fennerty R Sampliner S Spechler A Cameron D Corley G Falk J Goldblum J Hunter J Jankowski L Lundell B Reid NJ Shaheen A Sonnenberg K Wang W Weinstein 2004 A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop Gastroenterology 127 310 330 10.1053/j.gastro.2004.04.010
17. A Kubo DA Corley 2004 Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States Am J Gastroenterol 99 582 588 10.1111/j.1572-0241.2004.04131.x
18. C Hoppe RM Watson CM Long F Lorey L Robles W Klitz L Styles E Vichinsky 2006 Prevalence of HFE mutations in California newborns Pediatr Hematol Oncol 23 507 516 10.1080/08880010600751918
19. JP McClung LJ Marchitelli KE Friedl AJ Young 2006 Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army J Am Coll Nutr 25 64 69
20. E Beutler C West 2005 Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume Blood 106 740 745 10.1182/blood-2005-02-0713
21. V Ganji JS Hampl NM Betts 2003 Race-, gender- and age-specific differences in dietary micronutrient intakes of US children Int J Food Sci Nutr 54 485 490 10.1080/09637480310001622341
22. DJ Fleming PF Jacques KL Tucker JM Massaro RB D'Agostino Sr PW Wilson RJ Wood 2001 Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores Am J Clin Nutr 73 638 646
23. PC Adams AE Kertesz CE McLaren R Barr A Bamford S Chakrabarti 2000 Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors Hepatology 31 1160 1164 10.1053/he.2000.6984
24. N Aranda FE Viteri J Fernández-Ballart M Murphy V Arija 2007 Frequency of the hemochromatosis gene (HFE) 282C→Y, 63H→D, and 65S→C mutations in a general Mediterranean population from Tarragona, Spain Ann Hematol 86 17 21 10.1007/s00277-006-0179-0
25. N Krieger 1992 Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 703 710
26. Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia
27. G Block AM Hartman 1989 Issues in reproducibility and validity of dietary studies Am J Clin Nutr 50 1133 1138 discussion 1231-1235
28. G Block AM Hartman CM Dresser MD Carroll J Gannon L Gardner 1986 A data-based approach to diet questionnaire design and testing Am J Epidemiol 124 453 469
29. G Block FE Thompson AM Hartman FA Larkin KE Guire 1992 Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period J Am Diet Assoc 92 686 693
30. G Block M Woods A Potosky C Clifford 1990 Validation of a self-administered diet history questionnaire using multiple diet records J Clin Epidemiol 43 1327 1335 10.1016/0895-4356(90)90099-B
31. AC Massey 1992 Microcytic anemia. Differential diagnosis and management of iron deficiency anemia Med Clin North Am 76 549 566
32. Hillman RS (1998) Iron deficiency and other hypoproliferative anemias. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL (eds) Harrison's principles of internal medicine. McGraw-Hill, New York, pp 638-643
33. Beutler E, Hoffbrand AV, Cook JD (2003) Iron deficiency and overload. Hematology (Am Soc Hematol Educ Program) 2003:40-61. doi: 10.1182/asheducation- 2003.1.40
34. Y Zhao AS Ash RP Ellis JZ Ayanian GC Pope B Bowen L Weyuker 2005 Predicting pharmacy costs and other medical costs using diagnoses and drug claims Med Care 43 34 43
35. Y Zhao RP Ellis AS Ash D Calabrese JZ Ayanian JP Slaughter L Weyuker B Bowen 2001 Measuring population health risks using inpatient diagnoses and outpatient pharmacy data Health Serv Res 36 180 193
36. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume 1, the analysis of case-control studies. International Agency for Research on Cancer, Lyon, France
37. Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research. Principles and quantitative methods. Van Nostrand Reinhold, New York
38. Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York
39. DA Corley A Kubo TR Levin G Block L Habel W Zhao P Leighton C Quesenberry GJ Rumore PA Buffler 2007 Abdominal obesity and body mass index as risk factors for Barrett's esophagus Gastroenterology 133 34 41 10.1053/j.gastro.2007.04.046
40. P Preziosi S Hercberg P Galan M Devanlay F Cherouvrier H Dupin 1994 Iron status of a healthy french population: factors determining biochemical markers Ann Nutr Metab 38 192 202
41. EM Walker Jr SM Walker 2000 Effects of iron overload on the immune system Ann Clin Lab Sci 30 354 365
42. Y Luo ES Henle S Linn 1996 Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxycytidine family J Biol Chem 271 21167 21176 10.1074/jbc.271.35.21167
43. HW Hann MW Stahlhut CL Hann 1990 Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines Hepatology 11 566 569 10.1002/hep.1840110407
44. MT Barrett CA Sanchez LJ Prevo DJ Wong PC Galipeau TG Paulson PS Rabinovitch BJ Reid 1999 Evolution of neoplastic cell lineages in Barrett oesophagus Nat Genet 22 106 109 10.1038/8816
45. RL Nelson 2001 Iron and colorectal cancer risk: human studies Nutr Rev 59 140 148
46. GA Macdonald J Tarish VJ Whitehall SJ McCann GD Mellick RL Buttenshaw AG Johnson J Young BA Leggett 1999 No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation J Gastroenterol Hepatol 14 1188 1191 10.1046/j.1440-1746.1999.02027.x
47. RL Nelson FG Davis V Persky E Becker 1995 Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis Cancer 76 875 879 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0. CO;2-Q
48. ZF Zhang RC Kurtz GP Yu M Sun N Gargon M Karpeh Jr JS Fein S Harlap 1997 Adenocarcinomas of the esophagus and gastric cardia: the role of diet Nutr Cancer 27 298 309
49. Morrison AS (1992) Screening in chronic disease, 2. Oxford University Press, New York